Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — Investor Presentation (May 2024)
22 slides from Trendlines's investor presentation, May 2024
Slide 1: Investing to improve the human condition
Investing to improve the human condition Medtech & Agrifood Haim Brosh CEO May 2024
Slide 2: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 3: Who we are
Who we are We have established, built & continue to invest in our broad medtech and agrifood portfolio. Our goal is to achieve significant exits from our portfolio, bringing value to our shareholders. Trendlines is an Israel-headquartered company that trades in Singapore on the SGX (42T) and in the
Slide 4: Leadership
Leadership Haim Brosh Barak Singer CEO Trendlines Investments Steve Rhodes Israel Founder & Chair Emeritus 20 years’ managerial and financial Extensive investment Trendlines’ Founder; over 40 experience in public knowledge & experience years’ experience, deep and private companies. + strong manageri
Slide 5: Board of Directors
Board of Directors Nehama Ronen Elka Nir Interim Chair Lead Independent & External Director 20 years’ experience in public companies. 30 years’ experience She was Director in technology General of Israel’s management of Ministry of Environmental public and private Protection companies Sin Boon Ann P
Slide 6: A taste of our portfolio
A taste of our portfolio. “s: trendlines
Slide 7: Some portfolio stats
Some portfolio stats 44* 8 active consolidated portfolio companies companies in Singapore 16 28 agrifood medtech * including consolidated portfolio companies in Singapore 7
Slide 8: The natural food color revolution
The natural food color revolution A broad-spectrum of healthy plant-based colors produced via Founded 2018; fermentation technology, using baker’s yeast as a biofactory. 23 employees; Phytolon’s high-quality and cost-effective pigments offer value Yokne’am Illit, IL for consumers, the environment an
Slide 9: 4 more agrifood frontrunners
4 more agrifood frontrunners 16 agrifood portfolio companies Biological, environmentally- Celleste Bio has created a Artificial intelligence analytics Orally-administered disease friendly technology to control proprietary ‘cocoa technology’ employing drones for user- prevention for shrimp and fish t
Slide 10: Cryotherapy for superficial bladder cancer
Cryotherapy for superficial bladder cancer Cryotherapy to treat Non-Muscle Invasive Bladder Cancer to significantly improve quality of life. Founded 2015 Achievements CEO Eyal Kochavi • Closed US$16.5 million investment round including IP Submitted national strategic partner participation phase and
Slide 11: 4 more leading medtech companies
4 more leading medtech companies 28 medtech portfolio companies Incision-free & mesh-free treatment Next-generation aspiration catheter A small, game-changing Miniature implant for spinal for pelvic organ prolapse (POP) office- for treating ischemic stroke. device to prevent preterm birth. stability
Slide 12: Let's look at the numbers
Let's look at the “= trendlines
Slide 13: Portfolio cluster values
Portfolio cluster values Fair Value of Trendlines’ Non-IFRS* Value of Trendlines’ Share Cluster Share (US$'000) (additional information) (US$'000) Aquaculture & Animal Health US$ 2,543 US$ 3,316 Crop Protection US$ 6,089 US$ 9,778 Future Food & Ingredients US$ 10,451 US$ 14,225 Digitization & Roboti
Slide 14: FY 2023: Key Financial Metrics
FY 2023: Key Financial Metrics 31 December 2023 31 December 2022 Portfolio value: US$ 66.4 million US$ 89.8 million Total Equity: US$ 70.9 million US$ 97 million NAV per share: US$ 0.07 (S$0.09) US$0.11 (S$0.15) Net loss (US$34.7 million) (US$ 15.163 million) 14
Slide 15: Balance sheet (Group) - Assets
Balance sheet (Group) Assets (US$’000) (US$’000) Current assets 31 December 2023 31 December 2022 Non-current assets 31 December 2023 31 December 2022 Cash and cash Investments in portfolio 6,110 4,565 66,409 89,777 equivalents companies Short-term bank Accounts and other 90 2,092 28 1,489 deposits
Slide 16: Balance sheet (Group) - Liabilities
Balance sheet (Group) Liabilities (US$’000) (US$’000) Current liabilities 31 Dec 2023 31 Dec 2022 Long-Term liabilities 31 Dec 2023 31 Dec 2022 Lease liability 410 419 Loans from the Israel 2,258 2,469 Innovation Authority Short-term loan 342 292 Deferred revenues - 888 Trade and other 3,148 3,393 L
Slide 17: Consolidated condensed report of income (Group)
Consolidated condensed report of income (Group) Consolidated statements of profit or loss (US$’000) Income 31 Dec 2023 31 Dec 2022 Gain/(Loss) from change in fair value of investments in portfolio companies (27,032) (2,470) Income from services to portfolio companies 3,215 2,556 Income from contract
Slide 18: Consolidated condensed report of income (Group)
Consolidated condensed report of income (Group) Consolidated statements of profit or loss (US$’000) Expenses 31 Dec 2023 31 Dec 2022 Operating, general and administrative expenses 8,583 10,299 Operating, general and administrative expenses - Trendlines Medical 1,243 1,316 Singapore portfolio compani
Slide 19: Business developments in 2024
Business developments in 2024 • Management changes Following the retirement of Steve Rhodes and Todd Dollinger from their joint position of CEOs in 2023, Haim Brosh was appointed CEO. In February 2024, Steve & Todd retired from their positions as Chairs. Nehama Ronen was appointed Interim Chair. • S
Slide 20: Investing to improve the human condition
Investing to improve the human condition SGX: 42T Haim Brosh, CEO OTCQX: TRNLY haim@trendlines.com +972.72.260.7000 www.trendlines.com May 2024
Slide 21: Notes and Disclaimer
Notes and Disclaimer The non-IFRS fair value information does not represent any forecast or future performance but serves as an extra aid in evaluating our portfolio companies and investment approaches. The additional information (Non-IFRS value) which, as stated, differs from the IFRS fair value at
Slide 22: General Announcement
GENERAL ANNOUNCEMENT: INVESTOR PRESENTATION issuer & Securities issuer’ Manager THE TRENDLINES GROUP LTD. Securities THE TRENDLINES GROUP LTD. - 1L0011328855 - 42T Stapled Security No Announcement Details Announcement Title General Announcement Date GTime of Broadcast 28-May-2024 13:40:59 Status New
The Trendlines Group — Investor Presentation (May 2024) on 6ix